TransDigm Group (TDG)

NYSE Industrials Aerospace & Defense S&P 500
$1,197.01
+7.82 (+0.66%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+4.4%
1M+9.9%
3M-2.2%
6M-1.5%
YTD-10.0%
1Y-5.5%
3Y+44.5%
5Y+91.9%

Key statistics

Full financials →
Market cap$66.2B
P/E (TTM)36.3
EPS (TTM, diluted)$32.98
P/S6.61
P/B—
EV / EBITDA19.2
Revenue (TTM)$10.01B
Revenue growth+16.6%
Net margin21.3%
ROE—
Debt / equity—
FCF yield2.9%
Dividend yield—
Payout ratio—
Beta (1Y)0.72
Volatility (1Y)27.8%
52-week range$1,071.25 – $1,463.03
Avg volume (50D)369.96K

Revenue & net income — last 8 quarters

Statements →
Sep 29, 8:00 AM ET

TransDigm completes $3 billion senior secured notes offering due 2035

Neutral financing Written later 1.012.03

TransDigm Inc., a subsidiary of TransDigm Group, completed a $3 billion offering of 6.75% senior secured notes maturing January 2035 on September 28, 2026, at 100% of principal. The company plans to use the net proceeds to repurchase $2.1 billion of its 6.75% notes due 2028 through a tender offer and for general corporate purposes, which refinances existing debt and adds new long-term borrowing.

  • Notes: $3,000 million, 6.75% coupon, issued at 100.00% of principal, maturing January 31, 2035
  • Interest payable January 31 and July 31 each year, starting January 31, 2027
  • Proceeds intended to repurchase $2,100 million of 6.75% notes due 2028 via a tender offer launched September 14, 2026, plus general corporate purposes
  • Indenture dated September 28, 2026 includes covenants limiting additional debt, distributions and asset sales; trustee is The Bank of New York Mellon Trust Company, N.A.
Read the filing on SEC.gov ↗
Aug 4, 7:17 AM ET

TransDigm Q3 sales rise 23% and fiscal 2026 guidance is raised

Positive earnings Written later 2.02

TransDigm reported third-quarter fiscal 2026 results for the period ended June 27, 2026, with net sales of $2,741 million, up 23%, and net income of $540 million, up 10%. The company also raised its fiscal 2026 guidance, with the sales midpoint up $150 million, EBITDA As Defined up $100 million, and adjusted earnings per share up $1.52 at the midpoint, excluding the pending Prince & Izant acquisition.

  • Q3 net sales $2,741 million, up 23% from $2,237 million; net income $540 million, up 10%
  • Q3 EPS $9.39, up 11%; adjusted EPS $10.87, up 13%
  • EBITDA As Defined margin was 52.8%, down from 54.4% a year earlier
  • Fiscal 2026 adjusted EPS guidance $40.62 to $41.46; Q3 share repurchases of about $1.0 billion
Read the filing on SEC.gov ↗
Jul 24, 7:15 AM ET

TransDigm appoints Irina Krasik to board of directors, effective immediately

Neutral leadership Written later 5.02

TransDigm Group's board appointed Irina Krasik, a Managing Director at Stellex Capital Management, as a director effective immediately on July 22, 2026. She has not been named to any board committee, and the filing states no related person transactions or selection arrangements.

  • Irina Krasik appointed to the Board on July 22, 2026, effective immediately
  • Krasik has been with Stellex Capital Management since 2021 as a Managing Director, with prior roles at Bregal Investments, The Wicks Group, The Carlyle Group and Merrill Lynch
  • She has not been appointed to any board committee
  • She will receive standard non-employee director compensation, per the 2026 proxy statement
Read the filing on SEC.gov ↗
May 5, 7:17 AM ET

TransDigm raises fiscal 2026 guidance after 18% second-quarter sales growth

Positive guidance Written later 2.02

TransDigm reported second-quarter fiscal 2026 net sales of $2,544 million, up 18%, and net income of $536 million, up 12%. The company raised its full-year fiscal 2026 guidance at the midpoint for sales, EBITDA As Defined and adjusted earnings per share, while noting that net income guidance is roughly flat versus fiscal 2025 due to higher interest expense.

  • Q2 earnings per share were $9.20, up 12%; adjusted earnings per share were $9.85, up 8% from $9.11.
  • Fiscal 2026 sales guidance midpoint rose $420 million; EBITDA As Defined guidance midpoint rose $210 million.
  • Adjusted EPS guidance midpoint rose $1.14 to a range of $38.83 to $40.21.
  • Net income guidance of $2,026 million to $2,106 million implies a 0.4% decrease at the midpoint versus fiscal 2025.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Famous investors who own TDG

All investors →
InvestorValue% of portfolioLast quarter
Dan Loeb Third Point $105.23M2.25% Added
Lone Pine Capital $38.01M0.23% Reduced
Renaissance Technologies $34.13M0.05% Added
Ray Dalio Bridgewater Associates $2.47M0.01% Reduced

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All TDG congressional trades →
TradedMemberTypeAmount
Aug 25, 2026April McClain Delaney MD-06 · ChildSell$100,001 – $250,000
Jul 28, 2026April McClain Delaney MD-06 · ChildBuy$1,001 – $15,000
May 22, 2026April McClain Delaney MD-06 · ChildBuy$1,001 – $15,000
May 21, 2026April McClain Delaney MD-06 · ChildBuy$1,001 – $15,000
May 13, 2026April McClain Delaney MD-06 · ChildBuy$1,001 – $15,000
May 08, 2026April McClain Delaney MD-06 · ChildBuy$1,001 – $15,000
May 07, 2026April McClain Delaney MD-06 · ChildBuy$1,001 – $15,000
Apr 29, 2026April McClain Delaney MD-06 · ChildBuy$1,001 – $15,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Insider transactions

All insider trades →
DateInsiderTypeSharesPriceValue
Oct 15Reiss Joel
Co-Chief Operating Officer
Sell4.10K$1,128.04$4.62M

Prices are end-of-day and split-adjusted. Financial data from TransDigm Group's SEC XBRL filings. Not investment advice.